Ameritas Advisory Services LLC Acquires Shares of 4,937 Encompass Health Corporation $EHC

Ameritas Advisory Services LLC acquired a new stake in shares of Encompass Health Corporation (NYSE:EHC) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 4,937 shares of the company’s stock, valued at approximately $524,000.

Several other institutional investors have also added to or reduced their stakes in the business. Alliancebernstein L.P. lifted its holdings in shares of Encompass Health by 23.4% in the third quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock worth $319,567,000 after buying an additional 476,564 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Encompass Health by 0.5% in the third quarter. Dimensional Fund Advisors LP now owns 1,616,178 shares of the company’s stock valued at $205,279,000 after purchasing an additional 7,349 shares in the last quarter. Raymond James Financial Inc. raised its stake in Encompass Health by 34.8% in the third quarter. Raymond James Financial Inc. now owns 1,541,336 shares of the company’s stock valued at $195,780,000 after purchasing an additional 397,694 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Encompass Health by 5.3% in the third quarter. JPMorgan Chase & Co. now owns 1,410,335 shares of the company’s stock valued at $179,141,000 after purchasing an additional 70,387 shares in the last quarter. Finally, Millennium Management LLC raised its stake in Encompass Health by 140.0% in the third quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock valued at $155,430,000 after purchasing an additional 713,738 shares in the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

More Encompass Health News

Here are the key news stories impacting Encompass Health this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $6.35 from $6.32, suggesting stronger profit growth over the next couple of years.
• Positive Sentiment: The firm also increased its FY2028 EPS forecast to $7.16 from $7.13 and lifted Q1 2028 EPS to $1.80 from $1.73, reinforcing a favorable longer-term earnings trend.
• Positive Sentiment: Despite the revisions, the latest consensus still points to solid earnings for Encompass Health, with analysts expecting about $5.97 per share for the current full year and a “Buy” consensus recommendation from analysts. Article: Encompass Health Corporation (NYSE:EHC) Receives Consensus Recommendation of “Buy” from Analysts
• Neutral Sentiment: Several shorter-term estimates were only slightly adjusted, including FY2026 EPS cut to $5.96 from $6.03, with Q2 2026 lowered to $1.46 from $1.49 and Q3 2026 lowered to $1.36 from $1.40.
• Neutral Sentiment: Other quarterly forecasts were modestly lowered as well, including Q2 2027 to $1.60 from $1.62, Q3 2027 to $1.48 from $1.49, and Q4 2027 to $1.64 from $1.65.

Wall Street Analyst Weigh In

Several research firms have commented on EHC. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Barclays cut their target price on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $144.17.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the transaction, the executive vice president owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. The trade was a 2.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Treasurer Edmund Fay sold 11,937 shares of the business’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $107.00, for a total value of $1,277,259.00. Following the completion of the transaction, the treasurer directly owned 89,325 shares of the company’s stock, valued at approximately $9,557,775. This trade represents a 11.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.80% of the company’s stock.

Encompass Health Stock Performance

Shares of Encompass Health stock opened at $106.64 on Friday. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. The firm has a market capitalization of $10.58 billion, a P/E ratio of 17.80, a P/E/G ratio of 2.32 and a beta of 0.72. The business has a fifty day simple moving average of $102.94 and a two-hundred day simple moving average of $106.40. Encompass Health Corporation has a 12 month low of $92.77 and a 12 month high of $127.99.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.60 EPS for the quarter, beating the consensus estimate of $1.51 by $0.09. The business had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The company’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, equities analysts forecast that Encompass Health Corporation will post 5.96 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a $0.19 dividend. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. Encompass Health’s payout ratio is presently 12.69%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.